Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
MK-0812 for Reliable CCR2-Mediated Monocyte Trafficking Stud
2026-08-03
This article addresses experimental challenges in monocyte recruitment and CCR2-mediated inflammation assays, providing practical, evidence-based guidance on integrating MK-0812 (SKU A3611) into laboratory workflows. Researchers will find scenario-driven answers on protocol optimization, data interpretation, and vendor selection, with direct links to validated product and literature resources.
-
Diclofenac: Non-Selective COX Inhibitor in Organoid Research
2026-08-03
Diclofenac from APExBIO is setting new standards in applied inflammation and drug metabolism research, especially within hiPSC-derived intestinal organoid systems. This article translates the latest protocol enhancements and troubleshooting strategies into actionable workflows for scientists targeting cyclooxygenase inhibition and inflammation signaling pathways.
-
PP 3 as a Precision Tool for Dissecting Src Kinase Specifici
2026-08-02
Discover how 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine (PP 3), a research use only chemical, advances Src kinase pathway research with unmatched assay precision. This article uniquely examines negative controls within vascular signaling, integrating fresh evidence from ROS–kinase interplay.
-
PHF2 Histone Demethylase Regulates Neuroinflammation in Alzh
2026-08-01
The referenced study uncovers PHF2 as a key epigenetic regulator of inflammatory gene expression in Alzheimer’s disease, linking its activity to both neuroinflammation and cognitive deficits. By demonstrating that PHF2 knockdown restores synaptic function and memory in an AD mouse model, the work highlights PHF2 as a promising therapeutic target for neurodegenerative and neuroinflammatory conditions.
-
Triacetin Applications: Optimizing Assays and Tumor Models
2026-07-31
Triacetin (glyceryl triacetate) drives reproducibility in metabolic and oncology assays with its unique bioactivity and chemical stability. Explore advanced workflows, troubleshooting strategies, and protocol enhancements that leverage APExBIO’s Triacetin for high-impact, translational research.
-
WP1066: JAK2/STAT3 Inhibitor Workflows in Cancer and Regener
2026-07-31
WP1066 is a potent, cell-permeable JAK2/STAT3 inhibitor that empowers advanced oncology and regenerative medicine research. This guide details optimized protocols, novel applications, and troubleshooting strategies to maximize its utility in assays targeting cancer proliferation, angiogenesis, and immune modulation.
-
Fenipentol in Pancreatic Secretion & GI Research: Protocols
2026-07-30
Fenipentol (1-Phenyl-1-pentanol) offers unique, data-backed advantages for researchers investigating pancreatic and hepatobiliary secretion, inflammation, and metabolism in gastrointestinal physiology studies. Its distinct mechanism and robust workflow compatibility, as highlighted by recent network pharmacology and metabolomics, enable precise protocol optimization and troubleshooting.
-
Hydroxychloroquine Sulfate: Technical Guide for Disease Mode
2026-07-30
Hydroxychloroquine Sulfate is a synthetic quinoline derivative used to inhibit autophagy and toll-like receptor 7/9 signaling in autoimmune disease research. It is best suited for aqueous-based, short-term workflows targeting systemic lupus erythematosus and rheumatoid arthritis models, and should be avoided in protocols requiring organic solvent compatibility or long-term solution storage.
-
O6-Benzylguanine: Advancing MGMT Inhibition in Translational
2026-07-29
This thought-leadership article explores how O6-Benzylguanine, a potent MGMT inhibitor, is reshaping translational cancer research by enabling precise DNA repair inhibition and overcoming chemoresistance. Integrating mechanistic insights and strategic guidance, the article provides actionable protocol parameters and contextualizes emerging evidence on MGMT modulation—specifically referencing new findings on AP-2α-mediated MGMT suppression. APExBIO’s O6-Benzylguanine is positioned as a benchmark tool, with practical advice for researchers seeking to bridge preclinical discoveries and clinical impact.
-
Bortezomib (PS-341): Proteasome Inhibition and Metabolic Con
2026-07-29
Explore how Bortezomib (PS-341) enables precision proteasome inhibition for apoptosis assays and metabolic regulation research. This article uniquely integrates new mitochondrial insights and practical protocol guidance for advanced cancer studies.
-
11β-HSD1 Inhibition Reduces Liver Fibrosis via Notch and NK
2026-07-28
A recent study demonstrates that selective inhibition of 11β-HSD1 markedly attenuates liver fibrosis in a chronic mouse model by suppressing the Notch signaling pathway and enhancing natural killer (NK) cell-mediated clearance of hepatic stellate cells. These findings provide a mechanistic basis for immunometabolic modulation in metabolic dysfunction-associated steatotic liver disease (MASLD) and suggest new targets for anti-fibrotic therapy.
-
Protein A/G Magnetic Co-IP/IP Kit: Precision in Protein-Prot
2026-07-28
The Protein A/G Magnetic Co-IP/IP Kit leverages recombinant magnetic bead technology for efficient and highly specific immunoprecipitation of protein complexes, streamlining workflows for protein-protein interaction analysis and antibody purification. This article translates the latest bench findings into actionable steps and troubleshooting strategies, highlighting how APExBIO’s kit advances experimental reproducibility and sensitivity over conventional methods.
-
Amyloid Beta-peptide (25-35): Applied Neurotoxicity Models
2026-07-27
Amyloid Beta-peptide (25-35) (Aβ25-35) has revolutionized Alzheimer's disease neurotoxicity modeling by enabling reproducible, quantitative studies of microglial polarization and amyloid aggregation. This article details optimized experimental workflows, troubleshooting strategies, and translational insights, leveraging the latest mechanistic findings to accelerate neurodegenerative disease research.
-
Spermine Tetrahydrochloride (B6522): Reliable Lab Solutions
2026-07-27
This evidence-driven guide explores how Spermine tetrahydrochloride (SKU B6522) from APExBIO directly addresses major challenges in cell viability, membrane protection, and protein crystallization workflows. Quantitative data, scenario-based Q&A, and protocol parameters help researchers optimize reproducibility and assay performance with this versatile polyamine.
-
OTUD3 Stabilizes SLC7A11 to Drive Sunitinib Resistance in cc
2026-07-26
This study uncovers how OTUD3 overexpression in clear cell renal cell carcinoma (ccRCC) promotes resistance to the tyrosine kinase inhibitor sunitinib by stabilizing SLC7A11 and suppressing ferroptosis. The findings highlight a pivotal mechanism of therapy resistance, pointing toward OTUD3 or ferroptosis pathway modulation as promising strategies to restore drug sensitivity.